Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>Products>This Product

Covance, Inc.

Product Description

Covance, with headquarters in Princeton, New Jersey, is one of the world’s largest and most comprehensive drug development services companies, with annual revenues greater than $2 billion, employees in more than 60 countries, and more than 11,000 employees worldwide.

Nonclinical Development: Toxicology, Research Products, Analytical Services

• Managed 443 compound development programs (>250 IND/CTA enabling), with  over 100 different sponsors, which led to 41 IND/CTA applications in 2009
• Performed best-in-class productivity cycle times: FIA to FIH in 22 weeks
• Dedicated Capacity Agreements with several major pharma customers
• Greater than 2.5M sq ft of research space

Clinical Development: Clinical Pharmacology, Clinical, Central Labs

• Supported 50% of latest breakthrough cancer treatments
• Supported development of the top 25 currently marketed medicines
• 70% of clinical programs on or ahead of enrollment timelines
• Broad-based, scalable and market-leading, Biomarker capability
• 99% of samples received within stability
• 145 million laboratory tests; 83,000 investigator sites; 100 countries
• Seven Clinical Pharmacology units with ~500 beds

Periapproval & Market Access

• Results-driven reimbursement support for >60% of the biologics market
• Designed and managed world’s largest safety registry ever – iPledge
• Team of experts dedicated to risk management and Pharmacovigilance
• Bi-coastal call center capabilities to deliver patient and physician support
Product Covance, Inc.
Company Covance - Service Directory
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Covance - Service Directory
210 Carnegie Center Princeton, New Jersey 08540 United States

Tel: +1.888.268.2623

Scientific News
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Study Finds Key Regulator in Pulmonary Fibrosis
Researchers identify an enzyme that could open the way to therpies for chronic fatal lung disease.
Signaling Pathway Could Be Key to Improved Osteoporosis Treatment
Inhibition of SIK2 enzyme both stimulates bone formation and reduces bone breakdown in animal model.
Ovarian Cancer Insight
Study showed tumours release cytokines to attract macrophages, which secrete growth factors that in turn promote tumour growth.
Substance Can Potentially Postpone Aging
Researchers bridge the gap between two main aging theories - repairs to the DNA and poor functioning mitochondria.
Untangling Cause Of Memory Loss In Neurodegenerative Diseases
NIH-funded mouse study identifies a possible therapeutic target for a family of disorders.
New Model for Understanding Human Myeloma
Researchers develop mouse model where mice carry six human genes involved in human tumour growth.
Preventing Alzheimer's in Mice
Researchers have prevented the Alzheimer’s development in mice by using a virus delivery system to transport a specific gene into the brain.
New Platform for Roundworms Could Speed Up Drug Delivery
Researchers have developed a large-scale in vitro drug discovery platform that could speed up scientific research.
Scientists Speed Up Muscle Repair
Researchers discovered genetically modified mice were able to support far more regenerative stem cells, for muscle repair, than previously thought.


SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos